Therapy Areas: Inflammatory Diseases
Celgene Corp. Announces Pomalyst Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma
...
CEL-SCI Presents New Data for Its LEAPS Vaccine in the Treatment of Rheumatoid Arthritis at the American Association of Immunologists 103rd Annual Meeting
17 May 2019 - - US-based CEL-SCI Corp.'s (NYSE American: CVM) senior vice president of research, cellular immunology Daniel Zimmerman, Ph.D. has presented new LEAPS data at the American Asso...
Teva Launches of a Generic Version of Delzicol Delayed-Release Capsules in the United States
16 May 2019 - - Israeli generic drug specialist Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) (TASE: TEVA) TODAY announced the launch of a generic version of Delzicol (mesalamine) delayed-rele...
Enzo Biochem Issued United States Patent for Treatment of Liver Cancer Using Ozanimod
16 May 2019 - - US-based molecular diagnostics company Enzo Biochem, Inc. (NYSE: ENZ) was issued US Patent No. 10,278,960 entitled "Sphingosine Pathway Modulating Compounds for the Treatment of C...
Vedanta Biosciences Closes Extended USD 45.5m Series C Financing
16 May 2019 - - US-based clinical-stage company Vedanta Biosciences has raised an additional USD 18.5m as an extension of its Series C financing, bringing the total for the round to USD 45.5m, the com...
Noveome Biotherapeutics Publishes Further Preclinical Results Supporting the Neuroprotective Properties of ST266 in Retinal Ganglion Cells
15 May 2019 - - US-based biopharmaceutical company Noveome Biotherapeutics, Inc has published preclinical results for ST266, its proprietary, cell-free platform biologic, published in the Journal...